… Endogenous transposable elements seem also to be inappropriately expressed in the
salivary gland tissue (Mavragani CP et al, unpublished observations). Independently of the …

… adrenal autoantigen—which was associated with adrenal gland hyporesponsiveness and
the presence of B cell activating cytokines at the level of salivary gland tissue (Mavragani et al.…

• Mild chronic renal compromise34 continued association with antibodies against neuropeptides.
42 Increased rates of neuroticism, psychoticism, obsessiveness, hypochondriasis, …

Objective: To investigate the effect of the tumour necrosis factor (TNF) blocking agent
infliximab in patients with treatment-resistant inflammatory myopathies. Methods: A total of 13 …

Both type I and II interferons (IFNs) have been implicated in the pathogenesis of Sjogren's
syndrome (SS). We aimed to explore the contribution of type I and II IFN signatures in the …

The heightened risk of non-Hodgkin lymphoma (NHL) development in primary Sjogren
syndrome (SS) is well established. Several adverse clinical and laboratory predictors have been …

Heightened rates of both cardiovascular (CV) events and subclinical atherosclerosis,
documented by imaging and vascular function techniques are well established in systemic lupus …

Sjogren’s syndrome (SS), a chronic autoimmune systemic disease affecting middle aged
women, is characterized by lymphocytic infiltration of the salivary and lachrymal glands …

Objective. Recent clinical trials suggest that etan-ercept is ineffective in controlling Sjögren’s
syndrome (SS). To address the hypothesis that tumor necrosis factor blockade can result in …

… Mavragani and Sagalovskiy contributed equally to this work. Dr. Crow has received
consulting fees from and has served as a member of the advisory boards of AstraZeneca, Bristol-…